INTERNATIONAL IMMUNOPHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2022-10-17 ms5000001856769052

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2022-08-19 148897a5m26(暂无昵称)

审稿速度:2.0
偏重的研究方向：药理学
经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急

34 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2021-09-06 ms2000002145400630

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩

87 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2022-07-04 ms3000001697419776

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：免疫;药理学;炎症
经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。

0 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2022-10-06 ms7000002039636895

问下这个杂志收meta分析吗？

23 0

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2019-05-07 1257bf0bm18暂无昵称

审稿速度:1.0 | 投稿命中率:50.0
经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2022-09-24 ms8000000702123863

请问有几个审稿人回复才会给意见啊?

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2021-09-29 1881f2d278m

一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了...

64 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2022-09-21 ms2000001143063837

被预警了吗

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2094167, encodeId=9ea0209416e06, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：各位大佬，请问怎么查看有几个审稿人完成评论啊，投稿后通讯作者只收到1封邮件，按照链接登录进去只能看到状态时under review，但是看不到审稿人的情况啊，不知道评论里的各位大佬在哪里看到的，跪求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 17 10:34:54 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239689, encodeId=6fcb123968935, content=审稿速度:2.0 偏重的研究方向：药理学 经验分享：6.27投稿，7.5under review，8.15日期更换一下，但状态还是under review。是没希望还是没找到审稿人，继续找审稿人，，，焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53385311098, createdName=148897a5m26(暂无昵称), createdTime=Fri Aug 19 11:10:32 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230502, encodeId=4029123050203, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：免疫;药理学;炎症 经验分享：非常好的一个杂志，审稿速度非常快，编辑和审稿人非常nice，效率很高，而且最近影响因子也涨啦，已成功接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030f5614126, createdName=ms3000001697419776, createdTime=Mon Jul 04 16:17:09 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092102, encodeId=4f2f2092102e4, content=问下这个杂志收meta分析吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a96e6160534, createdName=ms7000002039636895, createdTime=Thu Oct 06 17:55:24 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570549, encodeId=af0c5e054959, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：今早上的好消息，刚被接受。编辑很友好，速度超快的，没送过外审，编辑自己就决定了，几天就给了审稿意见，然后大修了一次，花八天时间改好后，重新提交，三天就给消息了，编辑真的很友好，很有效率，各位有高质量的文章，又急需用的话，投这个很可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d2c2568895, createdName=1257bf0bm18暂无昵称, createdTime=Tue May 07 00:00:00 CST 2019, time=2019-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090104, encodeId=b2a2209010493, content=请问有几个审稿人回复才会给意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f9e8146355, createdName=ms8000000702123863, createdTime=Sat Sep 24 12:16:15 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055978, encodeId=8d0f10559e816, content=一审大修，返回后三天就required review completed了，然后好几天没动静了，会不会是被拒了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238f2084097, createdName=1881f2d278m, createdTime=Wed Sep 29 10:16:53 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089610, encodeId=18bd208961014, content=被预警了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Wed Sep 21 20:40:53 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248836, encodeId=5cdf1248836ff, content=被预警了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8438297255, createdName=ms4000001968374465, createdTime=Wed Sep 14 10:26:38 CST 2022, time=2022-09-14, status=1, ipAttribution=)]

2022-09-14 ms4000001968374465

被预警了。。。

27 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务